Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VC005 in mild to moderate atopic dermatitis
NCT07592585Phase 3Recruiting
- Sponsor
- Jiangsu Vcare PharmaTech Co., Ltd.
- Start
- May 2026
- Primary completion
- May 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of VC-005 in atopic dermatitis (AD), sponsored by Jiangsu Vcare PharmaTech Co., Ltd.. Started May 2026; status: recruiting.
02
Drugs
VC-005
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT07592585.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07592585.